ArticleJapanese journal of clinical oncology2021

Cost-effectiveness analysis of enzalutamide for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer in Japan.

Hiroyuki Okumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.